COVID19 impact on the global supply management for Pharmaceuticals

Investec India had hosted William Marth, President & CEO - Emcure Pharmaceuticals (North America & Europe Business) to discuss the US Generic market and the concerns around the global supply management. Mr Marth said that there was angst in the supply chain management as the demand for other products related to COVID19 ailments like ventilators have gone up dramatically in the past few months, putting pressure on the suppliers. Moreover customers were protecting themselves by buying more as inventory. The keen question was will the supply chain hold up.
Mr. Marth is currently the President & CEO for North America & Europe business of Emcure / Heritage Pharma. Prior to joining Emcure in 2018 he served as the President & CEO for AMRI (Albany Molecular Research Institute) (2012-18) and prior to that he worked as the President & CEO of Teva Americas where he played a key role in establishing Teva Pharmaceuticals as a leading specialty pharmaceuticals company.